Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

Osteoporosis is typically treated with orally administered drugs, which may take up to a year to have a noticeable effect. A ...

Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of ...

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...

Broken hips kill as many women as breast cancer thanks to weakened bones, so why is no one testing those who are most at risk ...

We live in a world where sitting for hours is normal—working at desks, watching TV, or scrolling on phones. It might feel ...

Although osteoporosis and related fractures impose a significant and growing burden, the management of this disease, even following fractures, is on the decline. A pilot study published in Archives of ...

Bimagrumab, a drug originally developed for muscle loss, may help reduce the risk of osteoporosis in weight loss medication ...

Weight loss medication has taken the world by storm and helped many overweight people. But for some, significant weight loss also comes with a loss of muscle mass and can lead to an increased risk of ...

Feb. 10, 2025 — Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk.

This report highlights the diagnostic challenges of SM, emphasize its underrecognized role in osteoporosis and fragility fractures, and advocates for ...